ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,1,Neoplasm of appendix,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
7,2,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
8,1,Rash maculovesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Acne,Acnes,Skin appendage conditions,Skin,N
10,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
11,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
12,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
14,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
15,1,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
16,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
16,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
18,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
19,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
20,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
21,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
22,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
22,2,Mouth cyst,Benign oral cavity neoplasms,Benign neoplasms gastrointestinal,Gastr,N
22,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
23,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
23,2,Headache,Headaches NEC,Headaches,Nerv,N
23,3,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
23,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
24,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
24,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
24,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
25,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
26,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
26,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
27,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
27,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
28,2,Headache,Headaches NEC,Headaches,Nerv,N
28,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
28,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
28,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
29,2,Headache,Headaches NEC,Headaches,Nerv,N
30,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
31,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
31,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
31,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
31,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
33,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
33,2,Abscess neck,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
33,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
33,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
35,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
35,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
35,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
36,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
36,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
36,3,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
37,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
38,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
38,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
39,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
41,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
42,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
42,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
42,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
42,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
42,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
44,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
45,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
46,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
46,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
46,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
47,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
47,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
48,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
48,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
48,3,Headache,Headaches NEC,Headaches,Nerv,N
48,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
48,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
48,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
48,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
49,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
49,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
49,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
50,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
51,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
51,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
51,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
51,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
51,5,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
51,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
52,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
52,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
53,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
53,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
53,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
53,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
53,5,Headache,Headaches NEC,Headaches,Nerv,N
53,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
54,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
54,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
54,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
55,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
55,2,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
55,3,Metastases to ovary,Metastases to specified sites,Metastases,Neopl,N
55,4,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
56,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
56,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
56,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
56,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
57,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
57,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
58,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
58,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
58,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
58,4,Headache,Headaches NEC,Headaches,Nerv,N
58,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
58,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
58,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
58,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
58,10,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
58,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
59,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
59,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
59,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
59,4,Headache,Headaches NEC,Headaches,Nerv,N
59,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
60,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
60,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
60,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
62,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
62,2,Headache,Headaches NEC,Headaches,Nerv,N
62,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
62,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
63,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
63,2,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
64,1,Carcinoid tumour pulmonary,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
64,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
65,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
65,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
65,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
66,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
66,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
66,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
66,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
67,1,Precancerous cells present,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
68,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
68,2,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
69,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
69,2,Headache,Headaches NEC,Headaches,Nerv,N
69,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
70,2,Headache,Headaches NEC,Headaches,Nerv,N
70,3,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
71,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
71,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
72,1,Headache,Headaches NEC,Headaches,Nerv,N
73,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
73,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
73,3,Headache,Headaches NEC,Headaches,Nerv,N
74,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
75,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
75,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
76,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
77,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
78,1,Headache,Headaches NEC,Headaches,Nerv,N
79,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
80,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
80,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
81,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
82,1,Headache,Headaches NEC,Headaches,Nerv,N
82,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
82,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
82,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
82,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
83,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
84,1,Acute sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
85,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
85,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,3,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
85,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
85,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
85,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
86,2,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
87,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
87,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
88,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
88,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
88,3,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
89,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
90,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
90,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
91,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
91,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
91,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
92,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
93,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
94,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
95,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
96,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
97,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
98,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
99,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
100,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
101,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
101,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
102,1,Colorectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
102,2,Malignant gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
102,3,Malignant peritoneal neoplasm,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
102,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
102,5,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
104,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
105,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
106,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
106,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
107,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
109,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
109,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
109,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
110,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
110,3,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
110,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
110,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
110,6,Oral lichenoid reaction,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
110,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
111,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
111,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
111,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
112,1,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
113,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
113,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
114,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
114,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
114,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
115,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
116,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
117,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
118,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
118,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
118,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
119,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
120,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
120,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
121,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
122,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
122,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
122,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
122,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
123,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
124,1,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
124,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
125,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
126,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
127,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
127,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
128,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
128,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
131,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
132,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
132,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
132,3,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
132,4,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
133,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
134,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
134,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
134,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
135,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
136,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
137,1,Magnesium deficiency,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
138,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
138,2,Migraine,Migraine headaches,Headaches,Nerv,N
138,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
139,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
139,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
139,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
140,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
140,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
142,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
142,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
142,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
142,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
142,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
143,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
143,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
143,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
143,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
143,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
143,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
144,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
144,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
145,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
146,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
146,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
146,3,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
146,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
146,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
146,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
147,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
147,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
147,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
148,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
149,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
149,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
150,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
151,1,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
152,1,Migraine,Migraine headaches,Headaches,Nerv,N
153,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
153,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
153,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
153,4,Headache,Headaches NEC,Headaches,Nerv,N
153,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
153,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
153,7,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
153,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
153,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
153,10,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,11,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
153,12,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
154,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
154,2,Occipital neuralgia,Headaches NEC,Headaches,Nerv,N
154,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
155,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
156,1,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
157,1,B-cell unclassifiable lymphoma high grade,B-cell unclassifiable lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
157,2,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
158,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
158,2,Pseudopolyp,Inflammations,General system disorders NEC,Genrl,N
158,3,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
159,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
159,2,Headache,Headaches NEC,Headaches,Nerv,N
159,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
160,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
160,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
161,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
161,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
161,4,Headache,Headaches NEC,Headaches,Nerv,N
161,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
161,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
162,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
162,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
162,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
163,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
163,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
164,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
164,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
164,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
164,5,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
164,6,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
164,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
164,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
165,1,Erythema annulare,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
166,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
167,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
168,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
169,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
169,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
169,3,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
169,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
171,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
172,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
173,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
173,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
175,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
175,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
176,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,1,Anal stenosis,Anal and rectal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
177,2,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
177,3,Rectal stenosis,Anal and rectal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
177,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,2,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
180,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
180,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,3,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
180,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
181,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
181,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
181,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
182,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
182,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
182,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
183,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
183,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
184,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
184,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
184,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
185,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
186,1,Headache,Headaches NEC,Headaches,Nerv,N
186,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
187,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
188,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
188,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
189,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
189,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
190,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
190,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
191,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
191,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
191,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
191,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
191,8,Headache,Headaches NEC,Headaches,Nerv,N
191,9,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
191,10,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
191,11,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
191,12,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
191,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
191,14,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
191,15,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
191,16,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
191,17,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
192,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
193,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
193,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
194,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
194,2,X-ray abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
195,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
195,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
195,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
195,5,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
195,6,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
195,7,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
195,8,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
195,9,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
195,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,11,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
196,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
196,2,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
196,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
196,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
196,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
197,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
198,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
198,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
198,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
198,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
199,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
199,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
200,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
200,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
200,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
200,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
201,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
202,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
203,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
204,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
205,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
205,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
205,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
206,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
206,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
206,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
207,1,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
207,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
207,3,Dilatation intrahepatic duct acquired,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
207,4,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
208,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
209,1,Headache,Headaches NEC,Headaches,Nerv,N
210,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
211,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
211,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
211,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
211,4,Renal embolism,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
211,5,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
211,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
212,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
212,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
212,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
213,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
213,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
213,3,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
213,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
214,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
215,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
216,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
216,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
216,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
217,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
217,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,1,Headache,Headaches NEC,Headaches,Nerv,N
218,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
219,1,Headache,Headaches NEC,Headaches,Nerv,N
219,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
220,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
220,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
221,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
222,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
223,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
223,2,Headache,Headaches NEC,Headaches,Nerv,N
223,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
224,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
225,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
225,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
225,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
225,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
225,5,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
225,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
226,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
227,1,Balanitis candida,Candida infections,Fungal infectious disorders,Infec,N
228,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
228,2,Headache,Headaches NEC,Headaches,Nerv,N
228,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
228,4,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
229,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
230,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
231,1,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
231,2,Respiratory moniliasis,Candida infections,Fungal infectious disorders,Infec,N
232,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
232,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
233,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
234,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
234,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
235,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
235,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
235,3,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
236,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
236,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
237,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
237,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
238,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
239,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
239,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
239,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
239,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
240,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
241,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
241,2,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
241,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
241,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
241,5,Fear of disease,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
241,6,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
241,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
241,8,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
241,9,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
241,10,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
241,11,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
241,12,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
242,1,Procedural dizziness,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
243,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
244,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
244,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
244,3,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
245,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
245,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
245,3,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
246,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
246,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
246,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
247,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
247,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
248,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
248,2,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
249,1,Headache,Headaches NEC,Headaches,Nerv,N
250,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
250,2,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
250,3,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
250,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
250,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
251,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
251,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
252,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
253,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
254,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
255,1,Headache,Headaches NEC,Headaches,Nerv,N
255,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
256,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
256,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
256,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
257,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
257,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
257,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
258,1,Headache,Headaches NEC,Headaches,Nerv,N
259,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
259,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
260,1,Headache,Headaches NEC,Headaches,Nerv,N
260,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
261,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
262,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
262,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
263,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
263,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
264,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
265,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
266,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
266,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
266,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
266,4,Headache,Headaches NEC,Headaches,Nerv,N
266,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
266,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
266,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
266,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
266,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
267,1,Headache,Headaches NEC,Headaches,Nerv,N
268,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
268,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
268,3,Headache,Headaches NEC,Headaches,Nerv,N
268,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
268,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
269,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
269,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
269,3,Large intestinal stenosis,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
269,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
269,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
269,6,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
270,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
270,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
271,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
272,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
273,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
274,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
275,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
276,1,Headache,Headaches NEC,Headaches,Nerv,N
277,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
277,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
278,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
278,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
278,3,Headache,Headaches NEC,Headaches,Nerv,N
278,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
279,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
280,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
281,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
281,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
282,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
282,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
283,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
284,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
285,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
286,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
286,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
286,4,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
287,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
287,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
287,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
287,4,Hepatitis E virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
287,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
287,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
288,1,Headache,Headaches NEC,Headaches,Nerv,N
289,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
290,1,Headache,Headaches NEC,Headaches,Nerv,N
291,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
292,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
293,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
293,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
293,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
293,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
293,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
293,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
293,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
294,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
294,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
294,3,Headache,Headaches NEC,Headaches,Nerv,N
295,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
295,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
295,3,Headache,Headaches NEC,Headaches,Nerv,N
296,1,Abscess of external ear,Ear infections,Infections - pathogen unspecified,Infec,N
296,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
296,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
297,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
298,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
299,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
299,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
299,3,Headache,Headaches NEC,Headaches,Nerv,N
299,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
300,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
300,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
300,3,Headache,Headaches NEC,Headaches,Nerv,N
301,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
301,2,Headache,Headaches NEC,Headaches,Nerv,N
302,1,Acute sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
302,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
302,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
303,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
303,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
304,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
304,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
304,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
305,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
305,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
305,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
306,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
307,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
307,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
307,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
308,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
308,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
308,3,Headache,Headaches NEC,Headaches,Nerv,N
309,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
310,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
311,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
311,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
311,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
311,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
311,5,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
312,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
312,2,Headache,Headaches NEC,Headaches,Nerv,N
313,1,Thyroiditis acute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
314,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,2,Throat clearing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
315,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
315,2,Headache,Headaches NEC,Headaches,Nerv,N
315,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
315,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
316,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
316,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
317,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
317,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
318,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
318,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
319,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
319,2,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
319,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
319,4,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
319,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
319,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
319,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
319,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
319,9,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
319,10,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
319,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
320,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
320,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
320,3,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
321,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
322,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
323,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
324,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
324,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
324,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
325,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
325,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
325,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
325,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
325,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
327,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
328,1,Headache,Headaches NEC,Headaches,Nerv,N
329,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
329,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
329,3,Peripartum cardiomyopathy,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
329,4,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
330,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
331,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
331,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
332,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
332,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,3,Proctocolectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
332,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
333,1,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
334,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
335,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
335,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
336,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
337,1,Migraine,Migraine headaches,Headaches,Nerv,N
338,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
339,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
340,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
341,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
341,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
341,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
341,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
342,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
342,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
342,3,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
342,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
343,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
344,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
345,1,Rectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
346,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
346,2,Headache,Headaches NEC,Headaches,Nerv,N
347,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
348,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
348,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
348,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
348,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
348,5,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
349,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
349,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
349,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
349,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
349,5,Systolic hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
350,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
351,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
351,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
352,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
352,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
352,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
352,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
352,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
352,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
352,7,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
353,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
353,2,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
354,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
355,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
355,2,Headache,Headaches NEC,Headaches,Nerv,N
355,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
357,1,Myopericarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
358,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
359,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
360,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
361,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
361,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
361,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
362,1,Headache,Headaches NEC,Headaches,Nerv,N
362,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
363,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
364,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
364,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
364,4,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
365,2,Headache,Headaches NEC,Headaches,Nerv,N
365,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
365,4,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
365,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
365,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
366,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
366,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
366,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
367,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
368,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
368,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
369,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
370,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
370,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
371,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
371,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
371,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
372,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
372,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
372,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
372,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
373,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
374,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
374,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
375,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
375,2,Headache,Headaches NEC,Headaches,Nerv,N
375,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
376,1,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
377,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
377,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
377,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
378,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
378,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
378,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
378,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
379,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
379,2,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
379,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
380,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
381,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
381,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
382,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
382,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
383,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
383,2,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
383,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
383,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
383,5,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
383,6,Spinal column injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
384,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
384,2,Headache,Headaches NEC,Headaches,Nerv,N
384,3,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
384,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
385,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
386,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
386,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
387,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
388,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
389,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
389,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
390,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
391,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
392,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
393,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
394,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
394,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
395,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
396,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
398,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
398,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
398,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
398,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
399,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
399,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
400,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
400,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
400,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
402,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
402,2,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
403,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
403,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
404,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
405,1,Headache,Headaches NEC,Headaches,Nerv,N
406,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
407,1,Headache,Headaches NEC,Headaches,Nerv,N
408,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
408,2,Drug exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
408,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
409,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
409,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
410,1,Headache,Headaches NEC,Headaches,Nerv,N
411,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
412,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
412,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
412,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
413,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
413,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
414,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
414,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
415,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
415,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
416,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
416,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
417,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
418,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
419,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
419,2,Headache,Headaches NEC,Headaches,Nerv,N
420,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
420,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
420,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
421,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
422,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
423,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
424,1,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
425,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
426,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
426,2,Headache,Headaches NEC,Headaches,Nerv,N
427,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
428,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
429,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
430,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
431,1,Migraine,Migraine headaches,Headaches,Nerv,N
432,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
432,2,Headache,Headaches NEC,Headaches,Nerv,N
432,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
433,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
433,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
435,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
436,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
436,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
436,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
437,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
438,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
438,2,Patella fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
439,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
440,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
440,2,Pouchitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
441,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
441,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
442,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
443,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
444,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
445,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
445,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
445,3,Incisional drainage,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
446,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
446,2,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
446,3,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
447,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
447,2,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
448,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
449,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
450,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
450,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
451,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
451,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
451,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
451,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
451,5,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
451,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
451,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
452,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
452,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
452,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
452,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
452,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
452,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
452,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
452,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
452,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
452,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
452,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
452,12,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
453,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
453,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
453,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
453,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
453,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
453,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
453,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
453,8,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
453,9,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
453,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
453,11,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
453,12,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
453,13,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
453,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
453,15,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
453,16,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
453,17,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
453,18,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
453,19,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
453,20,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
453,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
454,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
454,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
454,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
454,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
454,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
455,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
455,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
456,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
456,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
456,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
456,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
457,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
458,1,Epiglottic cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
459,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
460,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
461,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
461,2,Acne,Acnes,Skin appendage conditions,Skin,N
462,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
463,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
464,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
464,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
464,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
464,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
465,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
465,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
465,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
465,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
465,5,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
466,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
467,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
468,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
469,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
469,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
469,3,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
469,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
469,5,Encephalitis haemorrhagic,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
469,6,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
469,7,Headache,Headaches NEC,Headaches,Nerv,N
469,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
470,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
471,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
471,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
471,3,Headache,Headaches NEC,Headaches,Nerv,N
471,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
472,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
472,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
472,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
472,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
472,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
472,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
473,1,Migraine,Migraine headaches,Headaches,Nerv,N
473,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
474,1,Headache,Headaches NEC,Headaches,Nerv,N
474,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
474,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
474,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
475,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
476,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
477,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
477,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
478,1,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
479,1,Spinal cord oedema,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
479,2,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
479,3,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
479,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
480,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
480,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
480,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
481,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
481,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
481,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
481,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
481,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
482,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
482,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
482,3,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
482,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,1,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
483,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
484,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
485,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
486,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
487,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
488,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
489,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
489,2,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
489,3,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
489,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
491,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
492,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
493,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
493,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
494,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
494,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
494,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
494,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
494,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
494,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
494,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
495,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
496,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
496,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
496,3,Headache,Headaches NEC,Headaches,Nerv,N
496,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
496,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
497,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
497,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
497,3,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
497,4,Headache,Headaches NEC,Headaches,Nerv,N
497,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
498,1,Sialoadenitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
499,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
500,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
500,2,Headache,Headaches NEC,Headaches,Nerv,N
501,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
501,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
502,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
503,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
503,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
504,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
504,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
505,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
506,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
506,2,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
506,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
506,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
507,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
508,1,T-cell lymphoma refractory,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
509,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
511,1,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
512,1,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
513,1,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
514,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
515,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
516,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
517,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
517,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
517,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
518,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
518,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
519,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
520,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
520,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
521,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
521,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
521,3,Ocular myasthenia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
522,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
522,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
522,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
523,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
523,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
524,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
525,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
525,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
526,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
526,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
527,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
528,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
528,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
529,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
529,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
529,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
530,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
531,1,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
532,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
532,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
532,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
533,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
534,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
535,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
536,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
536,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
537,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
538,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
539,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
539,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
540,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
541,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
541,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
541,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
542,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
542,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
542,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
543,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
543,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
544,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
544,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
544,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
545,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
546,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
547,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
547,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
548,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
548,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
548,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
548,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
548,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
549,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
550,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
550,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
551,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
551,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
551,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
552,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
552,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
552,3,Migraine,Migraine headaches,Headaches,Nerv,N
553,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
553,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
553,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
553,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
553,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
554,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
554,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
554,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
554,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
554,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
554,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
555,1,Carotid artery stenosis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
555,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
555,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
556,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
557,1,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
558,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
558,2,Myopathy,Myopathies,Muscle disorders,Musc,N
558,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
559,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
560,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
561,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
561,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
562,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
563,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
563,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
564,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
564,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
565,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
565,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
565,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
565,4,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
565,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
565,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
565,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
565,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
566,1,Bile duct stent insertion,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
566,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
566,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
566,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
567,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
567,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
568,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
568,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
568,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
568,4,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
568,5,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
569,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
570,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
571,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
571,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
571,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
571,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
571,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
571,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
571,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
571,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
572,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
573,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
574,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
574,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
575,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
576,1,Cardio-respiratory distress,Heart failures NEC,Heart failures,Card,N
576,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
576,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
576,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
577,1,Migraine,Migraine headaches,Headaches,Nerv,N
577,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
578,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
578,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
578,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
578,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
578,5,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
579,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
580,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
581,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
582,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
583,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
583,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
584,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
584,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
584,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,4,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
585,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
585,2,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
585,3,Internal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
586,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
586,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
586,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
586,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
587,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
588,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
589,1,Aortic valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
589,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
589,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
590,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
590,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
590,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
591,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
591,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
591,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
591,4,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
592,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
593,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
593,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
593,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
594,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
595,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
596,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
596,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
597,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
597,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
598,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
599,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
600,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
601,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
601,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
602,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
602,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
603,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
603,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
604,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
605,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
605,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
606,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
606,2,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
606,3,Urethral pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
607,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
607,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
607,3,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
607,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
607,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
607,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
607,7,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
607,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
608,1,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
608,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
608,3,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
608,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
608,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
608,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
609,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
609,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
609,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
609,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
609,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
610,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
610,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
610,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
610,4,Vestibular neuronitis,Viral infections NEC,Viral infectious disorders,Infec,N
611,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
611,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
611,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
612,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
613,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
613,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
613,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
614,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
614,2,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
615,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
615,2,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
615,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
615,4,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
615,5,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
615,6,Hand fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
615,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
615,8,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
615,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
616,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
617,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
617,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
617,3,Nasal mucosal blistering,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
617,4,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,1,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
618,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
619,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
619,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
619,3,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
619,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
619,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
619,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
621,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
621,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
621,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
621,4,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
621,5,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
621,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
621,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
622,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
622,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
622,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
622,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
623,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
623,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
624,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
625,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
626,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
626,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
626,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
627,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
628,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
628,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
628,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
628,4,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
628,5,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
628,6,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
628,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
628,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
629,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
629,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
629,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
629,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
629,6,Retrograde ejaculation,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
629,7,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
630,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
630,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
631,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
632,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
632,2,Headache,Headaches NEC,Headaches,Nerv,N
632,3,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
632,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
633,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
634,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
634,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
634,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
634,4,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
634,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
634,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
635,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
635,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
636,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
636,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
636,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
637,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
637,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
638,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
638,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
639,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
639,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
640,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
640,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
640,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
640,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
640,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
640,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
640,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
640,8,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
642,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
642,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
642,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
643,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
643,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
643,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
644,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
645,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
645,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
646,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
646,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
646,3,Migraine,Migraine headaches,Headaches,Nerv,N
646,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
646,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
647,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
647,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
647,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
647,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
647,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
648,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
648,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
648,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
649,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
649,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
649,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
649,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
649,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
650,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
651,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
651,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
652,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
652,2,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
652,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
653,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
653,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
653,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
653,4,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
653,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
653,6,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
653,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
653,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
653,9,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
653,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
653,11,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
653,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
653,13,Medical device site pain,Complications associated with device NEC,Complications associated with device,Genrl,N
653,14,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
653,15,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
653,16,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
653,17,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
653,18,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
653,19,Retinal vascular thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
653,20,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
653,21,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
653,22,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
654,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
655,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
655,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
655,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
655,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
655,5,Tension headache,Headaches NEC,Headaches,Nerv,N
656,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
656,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
656,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
656,4,Endoscopic retrograde cholangiopancreatography abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
656,5,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
656,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
656,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
656,8,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
656,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
657,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
658,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
658,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
659,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
659,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
659,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
660,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
660,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
660,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
660,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
661,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
661,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
661,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
662,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
663,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
663,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
663,3,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
663,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
664,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
664,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
664,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
664,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
664,5,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
664,6,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
664,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
664,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
664,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
664,10,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
664,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
664,12,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
664,13,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
664,14,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
664,15,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
664,16,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
664,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
664,18,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
664,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
665,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
665,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
665,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
665,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
665,5,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
666,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
666,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
666,3,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
667,1,Headache,Headaches NEC,Headaches,Nerv,N
667,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
668,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
668,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
669,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
669,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
670,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
670,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
670,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
671,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
671,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
671,3,Sinus headache,Headaches NEC,Headaches,Nerv,N
671,4,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
672,1,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
672,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
672,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
672,4,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
672,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
673,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
673,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
673,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
673,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
673,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
673,6,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
674,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
674,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
674,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
675,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
675,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
676,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
676,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
677,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
677,2,Device leakage,Device issues NEC,Device issues,Prod,N
677,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
677,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
677,5,Migraine,Migraine headaches,Headaches,Nerv,N
677,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
678,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
679,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
679,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
680,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
680,2,Headache,Headaches NEC,Headaches,Nerv,N
680,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
680,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
680,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
682,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
682,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
683,1,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
683,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
683,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
683,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
684,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
684,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
685,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
685,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
685,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
685,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
686,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
687,1,Chalazion,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
687,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
687,3,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
687,4,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
687,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
688,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
688,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
688,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
689,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
689,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
689,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
690,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
690,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
691,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
692,1,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
693,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
694,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
694,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
694,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
694,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
694,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
695,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
695,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
695,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
696,1,Neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
697,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
697,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
698,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
698,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
698,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
698,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
699,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
699,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
699,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
699,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
699,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
699,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
699,7,Oropharyngeal spasm,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
699,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
699,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
700,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
700,2,Ventricular assist device insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
701,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
701,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
701,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
703,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
703,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
703,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
704,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
705,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
705,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
705,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
705,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
705,5,Urinary retention postoperative,Urinary tract procedural complications,Procedural related injuries and complications NEC,Inj&P,N
706,1,Headache,Headaches NEC,Headaches,Nerv,N
706,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
706,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
706,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
706,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
707,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
707,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
707,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
707,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
708,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
709,1,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
709,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
709,3,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
709,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
709,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
710,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
710,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
711,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
711,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
711,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
711,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
711,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
712,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
712,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
713,1,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
714,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
714,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
714,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
714,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
714,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
714,6,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
714,7,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
714,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
714,9,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
714,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
714,11,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
714,12,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
714,13,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
714,14,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
714,15,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
714,16,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
714,17,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
714,18,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
714,19,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
714,20,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
714,21,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
714,22,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
714,23,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
714,24,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
714,25,Rectal discharge,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
714,26,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
715,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
716,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
717,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
717,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
717,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
717,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
718,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
719,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
719,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
719,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
719,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
719,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
719,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
719,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
719,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
719,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
719,10,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
719,11,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
719,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
719,13,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
719,14,Medical device site pain,Complications associated with device NEC,Complications associated with device,Genrl,N
719,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
719,16,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
719,17,Spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
719,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
719,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
719,20,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
720,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
720,2,Headache,Headaches NEC,Headaches,Nerv,N
720,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
720,4,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
720,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
721,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
721,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
721,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
721,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
722,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
722,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
722,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
722,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
723,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
723,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
724,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
724,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
725,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
725,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
725,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
725,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
725,5,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
725,6,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
725,7,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
725,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
725,9,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
725,10,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
726,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
726,2,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
727,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
728,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
728,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
728,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
728,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
728,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
730,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
730,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
730,3,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
730,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
730,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
730,6,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
730,7,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
730,8,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
730,9,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
731,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
732,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
733,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
733,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
733,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
734,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
735,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
735,2,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
736,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
737,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
738,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
738,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
739,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
739,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
739,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
740,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
741,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
742,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
742,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
742,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
742,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
742,5,Headache,Headaches NEC,Headaches,Nerv,N
742,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
743,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
743,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
744,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
744,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
744,3,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
744,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
745,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
745,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
745,3,Migraine,Migraine headaches,Headaches,Nerv,N
746,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
747,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
748,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
748,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
748,3,Endometrial ablation,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
748,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
748,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
748,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
749,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
749,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
750,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
750,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
752,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
753,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
754,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
754,2,Headache,Headaches NEC,Headaches,Nerv,N
755,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
755,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
755,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
755,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
755,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
755,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
757,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
758,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
758,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
758,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
759,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
759,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
759,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
760,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
761,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
761,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
761,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
762,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
762,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
762,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
762,4,Eyelid thickening,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
762,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
762,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
762,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
762,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
763,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
763,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
763,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
763,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
764,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
764,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
764,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
765,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
765,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
765,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
766,1,Headache,Headaches NEC,Headaches,Nerv,N
767,1,Headache,Headaches NEC,Headaches,Nerv,N
767,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
767,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
768,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
768,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
769,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
769,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
769,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
769,4,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
769,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
770,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
770,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
770,3,Vaccination site erythema,Vaccination site reactions,Administration site reactions,Genrl,N
770,4,Vaccination site induration,Vaccination site reactions,Administration site reactions,Genrl,N
770,5,Vaccination site inflammation,Vaccination site reactions,Administration site reactions,Genrl,N
770,6,Vaccination site warmth,Vaccination site reactions,Administration site reactions,Genrl,N
771,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
771,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
771,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
771,4,Headache,Headaches NEC,Headaches,Nerv,N
771,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
771,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
771,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
771,8,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
772,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
772,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
772,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
772,4,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
772,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
772,6,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
772,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
772,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
772,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
773,1,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
774,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
774,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
774,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
774,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
775,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
775,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
776,1,Thoracic vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
777,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
777,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
778,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
778,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
779,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
779,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
779,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
779,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
780,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
780,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
780,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
780,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
780,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
781,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
781,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
782,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
783,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
783,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
783,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
783,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
783,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
784,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
784,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
785,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
785,2,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
785,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
786,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
786,2,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
787,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
788,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
788,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
789,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
790,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
791,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
792,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
792,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
793,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
793,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
794,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
795,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
795,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
795,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
796,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
797,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
798,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
798,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
799,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
799,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
800,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
800,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
800,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
800,4,Headache,Headaches NEC,Headaches,Nerv,N
800,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
800,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
800,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
800,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
800,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
800,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
800,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
800,12,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
801,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
801,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
801,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
802,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
802,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
802,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
803,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
804,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
805,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
805,2,Headache,Headaches NEC,Headaches,Nerv,N
805,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
805,4,Migraine,Migraine headaches,Headaches,Nerv,N
805,5,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
805,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
806,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
806,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
807,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
807,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
807,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
807,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
807,5,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
807,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
807,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
807,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
807,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
808,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
808,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
808,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
808,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
808,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
808,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
809,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
809,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
809,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
809,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
810,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
810,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
811,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
811,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
811,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
811,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
812,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
812,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
812,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
813,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
813,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
814,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
814,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
814,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
814,4,Headache,Headaches NEC,Headaches,Nerv,N
814,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
814,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
814,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
815,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
815,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
815,3,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
815,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
816,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
816,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
816,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
816,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
816,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
816,6,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
816,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
817,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
817,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
818,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
818,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
818,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
818,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
818,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
819,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
819,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
820,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
821,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
822,1,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
823,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
824,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
824,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
824,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
825,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
825,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
825,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
825,4,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
826,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
826,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
826,3,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
826,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
827,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
827,2,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
827,3,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
828,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
828,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
828,3,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
828,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
828,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
828,6,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
828,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
829,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
829,2,Headache,Headaches NEC,Headaches,Nerv,N
829,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
829,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
830,1,Headache,Headaches NEC,Headaches,Nerv,N
830,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
830,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
831,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
831,2,Headache,Headaches NEC,Headaches,Nerv,N
831,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
831,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
832,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
832,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
833,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
833,2,Headache,Headaches NEC,Headaches,Nerv,N
833,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
834,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
834,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
834,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
834,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
835,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
835,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
836,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
836,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
837,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
837,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
838,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
838,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
839,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
839,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
840,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
840,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
840,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
840,4,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
840,5,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
840,6,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
840,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
840,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
840,9,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
840,10,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
840,11,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
841,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
841,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
841,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
842,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
843,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
843,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
844,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
844,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
844,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
845,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
846,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
846,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
847,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
847,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
848,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
848,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
849,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
849,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
849,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
850,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
851,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
852,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
852,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
853,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
854,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
854,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
854,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
855,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
855,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
856,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
858,1,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
859,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
860,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
861,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
861,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
862,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
863,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
863,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
863,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
863,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
864,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
864,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
865,1,SARS-CoV-1 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
865,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
866,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
867,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
868,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
868,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
869,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
869,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
870,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
870,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
870,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
870,4,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
870,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
870,6,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
870,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
870,8,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
870,9,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
870,10,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
870,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
870,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
870,13,Spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
871,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
872,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
873,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
873,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
873,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
874,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
874,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
874,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
874,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
875,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
875,2,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
875,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
875,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
875,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
876,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
876,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
876,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
877,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
877,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
878,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
879,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
879,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
880,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
880,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
881,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
881,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
882,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
883,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
883,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
883,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
884,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
884,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
885,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
885,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
885,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
885,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
886,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
887,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
887,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
888,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
888,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
888,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
888,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
889,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
889,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
890,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
890,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
891,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
892,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
892,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
893,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
894,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
894,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
895,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
896,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
897,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
897,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
898,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
898,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
898,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
899,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
900,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
900,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
901,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
901,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
902,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
902,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
903,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
903,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
904,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
904,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
904,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
905,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
905,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
906,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
906,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
906,3,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
906,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
907,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
907,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
907,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
907,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
908,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
908,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
908,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
909,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
910,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
911,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
911,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
912,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
912,2,Headache,Headaches NEC,Headaches,Nerv,N
912,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
913,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
913,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
913,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
913,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
913,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
913,6,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
913,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
913,8,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
913,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
913,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
913,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
913,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
913,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
913,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
913,15,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
913,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
913,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
914,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
914,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
914,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
915,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
915,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
916,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
917,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
917,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
917,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
918,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
919,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
919,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
920,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
920,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
921,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
921,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
921,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
921,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
921,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
922,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
922,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
923,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
923,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
924,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
924,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
925,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
925,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
925,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
926,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
927,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
927,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
927,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
928,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
928,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
928,3,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
928,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
929,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
930,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
930,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
931,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
932,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
933,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
934,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
934,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
935,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
935,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
936,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
936,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
936,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
936,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
937,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
938,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
938,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
939,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
941,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
941,2,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
941,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
942,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
943,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
945,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
945,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
946,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
946,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
946,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
947,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
948,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
948,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
949,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
949,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
950,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
950,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
950,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
951,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
951,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
952,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
953,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
953,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
954,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
954,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
954,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
955,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
955,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
956,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
956,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
957,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
957,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
958,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
958,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
959,1,Anal fissure,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
959,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
959,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
959,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
960,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
961,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
961,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
962,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
962,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
963,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
964,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
965,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
965,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
965,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
966,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
967,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
967,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
967,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
967,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
967,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
967,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
967,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
968,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
968,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
969,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
969,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
970,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
970,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
970,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
971,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
971,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
972,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
972,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
973,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
973,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
973,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
974,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
975,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
976,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
976,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
976,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
977,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
977,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
978,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
978,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
978,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
978,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
978,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
979,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
979,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
980,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
980,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
980,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
981,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
981,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
981,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
981,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
981,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
982,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
982,2,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
983,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
983,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
983,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
983,4,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
983,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
984,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
984,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
985,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
986,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
987,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
987,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
988,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
988,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
989,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
989,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
990,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
991,2,Erysipelas,Streptococcal infections,Bacterial infectious disorders,Infec,N
991,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
991,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
992,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
992,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
992,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
992,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
992,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
993,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
993,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
994,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
994,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
995,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
995,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
995,4,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
995,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
996,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
997,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
998,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
998,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
998,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
999,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
999,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1000,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1000,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1001,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1002,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1002,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1003,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1003,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1003,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1004,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1005,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1005,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1005,3,Oesophageal spasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1005,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1006,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1006,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1006,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1007,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1008,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1008,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1009,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1009,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1009,3,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1009,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1009,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1010,1,Migraine,Migraine headaches,Headaches,Nerv,N
1011,1,Alopecia universalis,Alopecias,Skin appendage conditions,Skin,N
1011,2,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1012,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1013,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1013,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1014,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1015,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1015,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1016,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1017,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1017,2,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1017,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1017,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1018,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1019,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1019,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1019,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1020,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1021,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1022,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1022,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1023,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1023,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1023,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1025,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1025,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1026,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1027,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1028,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1028,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1030,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1031,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1031,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1032,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1032,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1033,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1033,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1033,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1033,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1034,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1034,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1035,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1035,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1036,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1037,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1037,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1038,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1038,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1039,1,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1039,2,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1039,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1039,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1040,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1040,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1040,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1041,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1041,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1042,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1042,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1043,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1044,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1045,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1045,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1046,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1046,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1047,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1047,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1047,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1048,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1049,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1049,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1050,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1050,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1051,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1051,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1051,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1052,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1052,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1052,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1053,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1053,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1053,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1053,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1054,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1055,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1056,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1056,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1057,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1057,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1058,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1059,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1060,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1061,1,Headache,Headaches NEC,Headaches,Nerv,N
1061,2,Migraine,Migraine headaches,Headaches,Nerv,N
1061,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1062,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1062,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1062,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1062,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1063,1,Breast ulceration,Breast disorders NEC,Breast disorders,Repro,N
1063,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1064,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1064,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1065,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1066,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1066,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1067,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1067,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1068,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1069,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1069,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1070,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1070,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1070,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1071,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1071,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1072,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1073,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1073,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1074,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1074,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1075,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1075,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1075,3,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
1075,4,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1075,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1075,6,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1075,7,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1075,8,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1075,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1075,10,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1075,11,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1075,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1075,13,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1075,14,Gastric polyps,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
1075,15,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1075,16,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1075,17,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1075,18,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1075,19,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1075,20,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1075,21,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1075,22,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1076,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1076,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1077,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1077,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1078,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1078,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1079,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1080,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1081,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1082,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1082,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1083,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1083,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1084,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1084,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1085,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1086,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1086,2,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
1087,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1087,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1088,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1088,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1088,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1088,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1089,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1089,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1089,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1089,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1090,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1090,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1091,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1092,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1092,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1093,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1093,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1093,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1093,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1094,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1094,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1095,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1095,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1096,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1097,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1097,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1098,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1098,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1099,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1099,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1100,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1100,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1100,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1100,4,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1100,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1100,6,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1100,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1100,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1100,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1100,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1100,11,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1100,12,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1101,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
1102,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1102,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1102,3,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1102,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1102,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1102,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1102,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1102,8,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1102,9,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1102,10,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1102,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1102,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1102,13,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1102,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1102,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1102,16,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1102,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1102,18,White coat hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1103,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1104,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1104,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1105,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1105,2,Bone abscess,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1105,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1105,4,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
1105,5,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1105,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1106,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1106,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1107,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1107,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1108,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1109,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1110,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1110,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1110,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1110,4,Tension headache,Headaches NEC,Headaches,Nerv,N
1111,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1112,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1113,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1114,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1114,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1114,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1114,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1114,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1115,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1115,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1116,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1116,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1117,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1118,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1118,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1119,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1119,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1120,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1121,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1121,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1122,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1122,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1122,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1122,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1123,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1124,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1124,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1125,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1126,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1127,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1128,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1129,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1130,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1131,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1131,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1132,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1132,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1132,3,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1133,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1133,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1133,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1134,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1134,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1135,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1135,2,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
1135,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1136,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1137,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1138,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1139,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1139,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1140,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1141,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1141,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1141,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1141,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1141,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1142,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1142,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1142,3,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1143,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1143,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1143,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1143,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1143,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1143,6,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1143,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1143,8,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
1143,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1143,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1143,11,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1143,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1144,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1145,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1146,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1147,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1147,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1147,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1148,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1148,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1148,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1149,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1150,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1150,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1150,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1150,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
1150,5,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1151,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1151,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1152,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1153,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1153,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1153,3,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
1153,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1153,5,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1153,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1153,7,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1154,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1154,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1155,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1155,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1155,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1156,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1156,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1157,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1157,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1158,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1158,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1158,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1158,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1158,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1158,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1158,7,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1158,8,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1158,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1158,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1158,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1158,12,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
1158,13,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1159,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1159,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1160,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1161,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1162,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1163,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1163,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1163,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1164,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1164,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1165,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1166,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1167,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1167,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1168,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1169,1,Abnormal product of conception,Abortion related conditions and complications,Abortions and stillbirth,Preg,N
1170,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1171,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1171,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1171,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1171,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1171,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1172,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1172,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1173,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1173,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1174,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1174,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1175,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1176,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1176,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1177,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1178,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1179,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1179,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1180,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1180,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1181,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1182,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1182,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1182,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1182,4,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1183,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1184,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1185,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1185,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1186,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1186,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1186,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1186,4,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1186,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1186,6,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1186,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1187,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1187,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1188,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1189,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1190,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1191,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1191,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1192,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1192,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1193,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1194,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1195,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1195,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1195,3,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1196,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1197,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1198,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1199,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1200,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1200,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1201,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1202,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1202,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1203,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1203,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1204,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1205,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1206,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1206,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1206,3,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1206,4,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1206,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1207,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1207,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1208,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1208,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1209,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1209,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1210,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1210,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1211,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1212,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1212,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1213,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1213,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1214,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1214,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1215,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1215,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1215,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1215,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1215,5,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1215,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1215,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1215,8,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1215,9,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1215,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1215,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1216,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1216,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1216,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1216,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1217,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1218,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1218,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1218,3,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
1218,4,Headache,Headaches NEC,Headaches,Nerv,N
1218,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1219,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1220,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1220,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1220,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1221,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1221,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1221,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1221,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1221,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1221,6,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1221,7,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1221,8,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1221,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1222,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1222,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1222,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1223,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1224,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1224,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1224,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1225,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1225,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1226,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1226,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1226,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1227,1,Bartholin's cyst,Vulvovaginal cysts and neoplasms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1227,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1227,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1228,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1229,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1230,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1230,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1230,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1230,4,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1230,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1231,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1232,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1232,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1233,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1233,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1234,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1234,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1235,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1235,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1236,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1236,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1237,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1238,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1239,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1240,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1240,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1241,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1241,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1242,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1242,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1243,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1243,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1243,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1244,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1245,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1245,2,Infrequent bowel movements,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1245,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1245,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1246,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1247,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1248,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1249,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1250,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1250,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1251,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1251,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1252,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1252,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1253,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1254,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1254,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1254,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1255,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1255,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1256,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1256,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1256,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1257,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1258,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1258,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1258,3,Headache,Headaches NEC,Headaches,Nerv,N
1259,1,Headache,Headaches NEC,Headaches,Nerv,N
1259,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1260,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1260,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1260,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1261,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1261,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1261,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1262,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1263,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1263,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1264,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1264,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1265,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1265,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1266,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1266,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1266,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1267,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1267,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1267,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1268,1,Fistula discharge,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1268,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1268,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1269,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1269,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1270,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1270,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1271,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1271,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1271,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1271,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1271,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1272,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1273,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1274,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1274,2,Headache,Headaches NEC,Headaches,Nerv,N
1274,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1274,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1275,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1276,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1276,2,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1276,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1276,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1276,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1276,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1276,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1276,8,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
1277,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1277,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1277,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1278,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1278,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1279,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1279,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1280,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1280,2,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1281,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1281,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1282,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1282,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1283,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1284,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1285,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1285,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1285,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1285,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1285,5,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
1285,6,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1285,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1285,8,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1286,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1286,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1287,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1287,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1288,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1288,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1288,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1289,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1290,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1290,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1291,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1291,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1291,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1292,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1292,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1292,3,Headache,Headaches NEC,Headaches,Nerv,N
1292,4,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1292,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1292,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1292,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1293,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1293,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1294,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1295,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1295,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1296,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1296,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1297,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1297,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1298,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1298,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1298,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1299,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1299,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1300,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1300,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1301,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1302,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1302,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1303,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1303,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1303,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1303,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1304,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1304,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1305,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1305,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1305,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1305,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1305,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1305,6,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1305,7,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1305,8,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
1305,9,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1305,10,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1306,1,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
1307,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1308,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1309,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1310,1,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1310,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1310,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1311,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1311,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1311,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1311,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1311,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1311,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1311,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1312,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1312,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1312,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1312,4,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1312,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1312,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1312,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1312,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1312,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1312,10,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1312,11,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1313,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1313,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1313,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1314,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1314,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1315,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1315,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1316,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1317,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1317,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1318,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1318,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1319,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1319,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1320,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1321,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1321,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1322,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1323,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1324,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1325,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1325,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1326,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1327,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1328,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1329,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1329,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1330,1,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1330,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1330,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1330,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1331,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1332,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1333,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1333,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1333,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1334,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1335,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1335,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1336,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1336,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1336,3,Headache,Headaches NEC,Headaches,Nerv,N
1336,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1336,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1337,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1337,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1338,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1339,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1339,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1339,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1339,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1340,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1340,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1341,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1341,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1342,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1343,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1344,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1344,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1345,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1345,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1346,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1347,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1348,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1349,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1350,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1350,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1351,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1351,2,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
1351,3,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1351,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1352,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1352,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1353,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1353,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1353,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1354,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1354,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1354,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1355,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1355,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1356,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1356,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1357,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1357,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1357,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1357,4,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1357,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1358,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1359,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1359,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1360,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1360,2,Headache,Headaches NEC,Headaches,Nerv,N
1360,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1360,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1360,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1360,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1361,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1361,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1362,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1362,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1362,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1362,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1362,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1363,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1363,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1364,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1365,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1366,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1367,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1367,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1368,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1368,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1368,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1368,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1368,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1368,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1368,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1369,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1369,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1370,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1370,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1371,1,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1372,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1372,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1373,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1373,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1373,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1373,4,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1374,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1374,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1374,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1375,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1375,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1376,1,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1377,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1377,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1378,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1378,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1379,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1380,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1380,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1380,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1380,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1381,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1381,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1382,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1382,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1382,3,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1382,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1382,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1382,6,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1382,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1383,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1383,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1383,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1383,4,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1383,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1383,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1384,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1384,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1384,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1384,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1384,5,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1384,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1385,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1386,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1386,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1386,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1387,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1387,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1388,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1388,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1388,3,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1388,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1388,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1388,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1388,7,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1389,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1389,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1390,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1391,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,2,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
1393,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1394,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1394,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1394,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1395,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1395,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1395,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1395,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1395,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1396,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1396,2,Pouchitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1397,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1397,2,Headache,Headaches NEC,Headaches,Nerv,N
1397,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1397,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1397,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1397,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1397,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1398,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1399,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1399,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1400,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1400,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1401,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1401,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1402,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1403,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1403,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1403,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1404,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1405,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1405,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1406,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1406,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1407,1,Incorrect dosage administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1407,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1407,3,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1407,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1408,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1409,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1410,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1410,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1411,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1412,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1412,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1413,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1414,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1414,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1414,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1414,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1415,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1415,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1415,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1415,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1415,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1415,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1416,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1417,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1417,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1417,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1417,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1417,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1418,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1419,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1419,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1420,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1420,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1421,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1422,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1422,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1423,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1424,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1424,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1424,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1425,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1425,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1425,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1426,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1426,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1427,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1428,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1428,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1428,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1428,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1429,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1430,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1430,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1430,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1430,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1431,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1432,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1432,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1434,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1435,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1435,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1436,1,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1437,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1437,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1438,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1438,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1438,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1438,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1438,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1438,6,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1438,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1438,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1439,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1440,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1441,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1442,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1442,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1442,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1443,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1443,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1444,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1444,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1445,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1445,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1445,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1446,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1447,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1447,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1448,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1448,2,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1448,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1449,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1449,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1450,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1450,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1450,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1451,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1452,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1452,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1453,1,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1453,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1454,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1454,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1454,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1454,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1455,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1455,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1456,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1456,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1457,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1458,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1459,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1460,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1460,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1461,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1462,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1463,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1463,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1464,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1465,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1466,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1467,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1468,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1468,2,Cardiac ablation,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
1468,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1468,4,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1468,5,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
1469,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1469,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1470,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
1470,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1471,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1471,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1472,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1472,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1473,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1474,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1475,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1475,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1476,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1476,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1477,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1477,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1477,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1477,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1477,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1478,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1479,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1479,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1480,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1480,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1481,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1481,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1482,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1482,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1483,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1484,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1484,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1485,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1486,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1487,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1487,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1488,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1488,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1489,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1490,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1490,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1491,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1491,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1492,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1492,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1493,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1493,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1493,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1494,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1494,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1495,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1495,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1496,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1496,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1496,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1497,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1497,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1498,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1498,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1499,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1499,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1499,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1500,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1501,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1501,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1501,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1501,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1501,5,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1501,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1501,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1502,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1502,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1503,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1503,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1504,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1504,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1505,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1506,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1507,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1508,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1509,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1510,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1511,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1512,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1513,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1514,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1514,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1515,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1515,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1515,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1516,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1516,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1516,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1516,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1517,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1518,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1518,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1518,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1519,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1520,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1520,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1521,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1521,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1522,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1522,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1523,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1523,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1524,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1525,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1525,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1525,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1526,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1526,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1527,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1527,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1528,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1528,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1529,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1529,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1529,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1530,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1531,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1531,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1531,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1531,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1532,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1533,1,Blast cell proliferation,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1533,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1534,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1534,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1535,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1535,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1536,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1537,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1537,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1538,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1539,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1540,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1540,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1541,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1542,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1542,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1543,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1544,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1545,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1546,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1547,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1547,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1547,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1547,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1548,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1549,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1549,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1549,3,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1549,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1550,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1551,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1551,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1551,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1552,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1552,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1552,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1552,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1552,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1553,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1554,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1554,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1554,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1554,4,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1554,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1554,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1554,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1554,8,Spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
1555,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1556,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1557,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1558,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1558,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1559,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1559,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1560,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1561,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1562,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1562,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1562,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1563,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1564,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1564,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1565,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1565,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1566,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1566,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1567,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1567,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1567,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1568,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1569,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1569,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1569,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1569,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1569,5,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1570,1,Glomerular filtration rate,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1571,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1571,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1572,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1573,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1574,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1574,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1575,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1575,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1575,3,Faecal calprotectin decreased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1575,4,Headache,Headaches NEC,Headaches,Nerv,N
1575,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1575,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1576,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1576,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1576,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1576,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1577,1,Headache,Headaches NEC,Headaches,Nerv,N
1577,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1578,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1579,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1579,2,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1579,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1579,4,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1579,5,Fistula discharge,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1579,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1579,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
1579,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1579,9,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1580,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1580,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1581,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1582,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1583,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1584,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1585,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1586,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1587,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1588,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1589,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1590,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1590,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1591,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1591,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1592,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1592,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1593,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1593,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1593,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1594,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1595,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1596,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1596,2,Device issue,Device issues NEC,Device issues,Prod,N
1596,3,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1597,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1598,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1599,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1599,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1600,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1600,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1601,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1602,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1603,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1603,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1603,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1603,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1603,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1604,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1605,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1606,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1606,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1607,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1607,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1608,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1608,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1608,3,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1608,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1608,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1608,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1608,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1608,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1608,9,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1608,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1608,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1608,12,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1608,13,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1608,14,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1608,15,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1608,16,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
1608,17,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1608,18,Migraine,Migraine headaches,Headaches,Nerv,N
1608,19,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1608,20,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1608,21,Radius fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1609,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1610,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1610,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1610,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1611,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1611,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1611,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1611,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1611,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1611,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1611,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1611,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1611,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1611,10,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1611,11,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1611,12,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1611,13,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1611,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1611,15,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1611,16,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1611,17,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1611,18,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1611,19,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1611,20,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1611,21,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1611,22,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1611,23,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1612,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1613,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1614,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1614,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1615,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1615,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1615,3,Intestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1615,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1615,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1615,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1616,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1616,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1617,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1618,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1619,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1619,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1620,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1621,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1622,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1623,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1624,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1625,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1625,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1626,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1627,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1627,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1628,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1628,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1629,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1630,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1631,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1631,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1631,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1631,4,Sialoadenitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1632,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1633,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1634,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1635,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1635,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1635,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1635,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1636,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1637,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1637,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1638,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1639,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1640,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1641,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1641,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1642,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1642,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1642,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1643,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1644,1,Migraine,Migraine headaches,Headaches,Nerv,N
1645,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1646,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1646,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1647,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1648,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1648,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1649,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1649,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1650,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1650,2,Headache,Headaches NEC,Headaches,Nerv,N
1651,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1651,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1652,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1653,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1653,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1653,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1654,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1655,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1656,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1657,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1658,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1659,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1660,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1661,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1661,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1661,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1661,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1661,5,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1662,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1663,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1663,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1664,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1665,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1665,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1665,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1665,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1666,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1666,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1666,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1666,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1667,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1668,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1669,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1670,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1671,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1672,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1672,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1673,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1673,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1673,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1673,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1673,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1673,6,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1673,7,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1674,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1674,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1675,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1675,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1676,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1676,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1676,3,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1676,4,Myopathy,Myopathies,Muscle disorders,Musc,N
1676,5,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
1676,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1676,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1676,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1677,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1677,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1678,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1679,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1679,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1679,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1679,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1680,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1680,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1680,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1681,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1681,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1682,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1683,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1683,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1683,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1684,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1685,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1685,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1685,3,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1685,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1686,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1687,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1687,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1687,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,6,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
1687,7,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1687,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1687,10,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1688,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1688,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1689,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1690,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1690,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1690,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1690,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1690,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1690,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1690,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1690,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1690,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1690,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1690,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1690,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1690,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1690,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1690,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1690,16,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1690,17,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1690,18,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1690,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1691,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1692,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1693,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1693,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1693,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1693,4,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1693,5,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
1694,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1694,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1694,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1694,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1694,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1694,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1694,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1694,8,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1694,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1694,10,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1694,11,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1695,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1695,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1695,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1695,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1695,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1695,6,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1695,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1695,8,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1695,9,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1695,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1695,11,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1695,12,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1696,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1697,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1697,2,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
1697,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1697,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1697,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1697,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1697,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1697,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1697,9,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1698,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1699,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1699,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1700,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1700,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1700,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1700,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1700,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1701,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1701,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1701,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,5,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1701,6,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1701,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1701,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1701,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1701,10,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1701,11,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1701,12,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1701,13,White coat hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1702,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1702,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1702,3,Pleural mass,Pleural conditions NEC,Pleural disorders,Resp,N
1703,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1704,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1704,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
1704,3,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1704,4,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1704,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1704,6,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1704,7,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1704,8,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1704,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1704,10,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1704,11,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1704,12,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1704,13,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1704,14,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1704,15,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1704,16,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1705,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1706,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1707,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
1707,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1707,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1707,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1707,5,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1707,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1707,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1707,8,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1707,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1707,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1707,11,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1707,12,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1708,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1708,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1708,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1708,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1709,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1710,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1710,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1710,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1710,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1710,5,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1710,6,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
1710,7,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1710,8,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1710,9,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
1710,10,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
1710,11,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1710,12,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1710,13,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1710,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1711,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1712,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1712,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1712,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
1713,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1713,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1713,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1713,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1713,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1714,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1714,2,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1714,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1714,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1714,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1714,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1715,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1715,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1715,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1716,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1716,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1716,3,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1716,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1716,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1716,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1717,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1717,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1717,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1718,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1718,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1718,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1718,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1719,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1719,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1719,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1720,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1720,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1720,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1721,1,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1721,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1721,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1722,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1723,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1723,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1723,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1723,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1723,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1724,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1724,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1724,3,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1724,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1724,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1724,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1725,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1725,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1725,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1725,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1726,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1726,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1726,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1727,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1728,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1728,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1728,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1728,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1729,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1729,2,Headache,Headaches NEC,Headaches,Nerv,N
1729,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1729,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1730,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1730,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1730,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1730,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1730,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1730,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1730,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1731,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1731,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1731,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1731,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1731,5,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1731,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1731,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1732,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1732,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1732,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1732,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1733,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1733,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1734,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1734,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1734,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1734,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1734,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1735,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1735,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1735,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1735,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1735,5,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1735,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1735,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1735,8,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1735,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1735,10,Pneumoconiosis,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
1735,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1735,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1736,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1736,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1736,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1737,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1737,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1737,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1737,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1737,5,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1738,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1738,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1738,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1739,1,Extragonadal primary seminoma (pure),Extragonadal primary germ cell neoplasms,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1740,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1740,2,Headache,Headaches NEC,Headaches,Nerv,N
1741,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1741,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1741,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1742,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1742,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1742,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1743,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
1744,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1745,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1746,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1747,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1748,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1748,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1748,3,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1749,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1749,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1749,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1749,4,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1750,1,Respiratory symptom,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
1751,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1752,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1753,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1754,1,Blood immunoglobulin G increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1754,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1755,1,Plantar fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1755,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1756,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1757,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1757,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1758,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1758,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1759,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
1760,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1761,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1762,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1763,1,Transitional cell cancer of the renal pelvis and ureter,Renal pelvis and ureter neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1764,1,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
1765,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1766,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1767,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1767,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1767,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1767,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1767,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1767,6,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1767,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1767,8,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1767,9,Tension headache,Headaches NEC,Headaches,Nerv,N
1767,10,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1768,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1768,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1768,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1768,4,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1768,5,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1769,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1769,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1770,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1771,1,Acne,Acnes,Skin appendage conditions,Skin,N
1771,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1771,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1771,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1771,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1771,6,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1772,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1773,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1773,2,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1773,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1773,4,Pouchitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1774,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1774,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1775,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1776,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1777,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1777,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1778,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1779,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1779,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1779,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1779,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1779,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1779,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1779,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1780,1,Dysplastic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1781,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1782,1,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1782,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1783,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1784,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1785,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1785,2,Rash papulosquamous,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1786,1,Dysplastic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1787,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1787,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1788,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1788,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1789,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1790,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1790,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1791,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1791,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1791,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1792,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1793,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1793,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1794,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1795,1,Tension headache,Headaches NEC,Headaches,Nerv,N
1796,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1796,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1797,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1798,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1799,1,Headache,Headaches NEC,Headaches,Nerv,N
1799,2,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1799,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1799,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1800,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1800,2,Headache,Headaches NEC,Headaches,Nerv,N
1800,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1801,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1801,2,Splenic vein thrombosis,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1802,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1802,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1802,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1802,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1802,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1802,6,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1803,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1803,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1803,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1804,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1805,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1805,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1806,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1806,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1806,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1807,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1807,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1807,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1807,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1807,5,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1807,6,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1807,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1807,8,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1807,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1808,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1808,2,Nasal oedema,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1808,3,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1809,1,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
1810,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1810,2,Glomerulonephritis proliferative,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1810,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1811,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1812,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1813,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1814,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1815,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1815,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1816,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1816,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1817,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1818,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1818,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1819,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1819,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1819,3,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1820,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1821,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1821,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1822,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1823,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1824,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1824,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1824,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1824,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1824,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1824,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1824,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1824,8,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1824,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1824,10,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1824,11,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1825,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1825,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1825,3,Headache,Headaches NEC,Headaches,Nerv,N
1825,4,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
1825,5,Narrow anterior chamber angle,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1825,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1825,7,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1825,8,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1826,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1827,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1828,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1829,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1829,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1829,3,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1830,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1830,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1830,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1830,4,Drug specific antibody absent,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1830,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1831,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1831,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1831,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1832,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1833,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1833,2,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1834,1,Headache,Headaches NEC,Headaches,Nerv,N
1835,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1836,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1836,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1836,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1837,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1838,1,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1839,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1840,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1841,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1841,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1841,3,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1842,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1843,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1844,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1845,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
